Nobel Prize in Chemistry Honors Asymmetric Catalysis for Safer Drug Synthesis

The 2026 Nobel Prize in Chemistry recognizes work on asymmetric catalysis, enabling selective production of desired molecular enantiomers, as highlighted by the Thalidomide case. This is a routine annual award, not a market-moving event. The recognition underscores the importance of the field in pharmaceutical manufacturing.